Canaan X

Canaan X, established in 2014, is an early-stage venture capital fund based in San Francisco, California, managed by Canaan Partners. The fund invests in early-stage companies across the United States, Israel, and India, focusing on software, healthcare, and technology, media, and telecommunications (TMT) sectors. Canaan X typically invests between $1 million to $20 million per company, supporting entrepreneurs from the early stages through expansion.

Brent Ahrens

General Partner

Nandu Anilal

Vice President, East Coast

John Balen

General Partner

Joydeep Bhattacharyya

General Partner

Laura Chau

General Partner - East Coast

Brendan Dickinson

General Partner - East Coast

Rayfe Gaspar-Asaoka

Partner

Nina Kjellson

General Partner

Jared Newman

Vice President, East Coast

John Pacifico

General Partner

Julie Papanek

Partner

Guy Russo

General Partner

Uwe Schoenbeck Ph.D

Venture Partner

Dana Warren

Venture Partner, East Coast

Past deals in Growth Stage

Cynomi

Series B in 2025
Cynomi offers an AI-powered, automated virtual Chief Information Security Officer (vCISO) platform designed to assist Managed Security Service Providers (MSSPs) and consulting firms in delivering vCISO services efficiently and at scale. Founded in 2021 and based in London, the company’s multi-tenant platform automatically generates essential components for vCISO services, including risk and compliance assessments, customized security policies, and actionable remediation plans with prioritized tasks. Additionally, it provides task management tools and customer-facing reports, ensuring that organizations can maintain optimal cybersecurity posture and regulatory compliance. Cynomi's solution enables businesses to enhance their security measures without the need to expand existing resources.

AttoTude

Series B in 2025
AttoTude is a technology company specializing in the development of advanced interconnect solutions for AI and hyperscale data centers. It aims to surpass the limitations of existing data networking systems by creating innovative technology that significantly boosts bandwidth, enhances reliability, and reduces power consumption and costs.

Nivoda

Series C in 2024
Nivoda Limited is a business-to-business online marketplace based in London, with an additional office in Hong Kong, that specializes in the buying and selling of diamonds and jewelry. Founded in 2017, Nivoda simplifies the global jewelry trade by providing a platform that connects jewelry businesses with verified suppliers, allowing them to browse a wide selection of diamonds and gemstones. The marketplace enables users to purchase goods efficiently from anywhere in the world through a single checkout process, helping clients source diamonds at competitive prices while minimizing logistical hurdles and additional costs associated with international purchases. Nivoda's aim is to enhance profits and accelerate growth for jewelry businesses by streamlining the sourcing process.

Halda Therapeutics

Series B in 2024
Halda Therapeutics is a research-stage drug discovery company focused on developing next-generation precision medicines. The company utilizes a novel therapeutic modality aimed at creating treatments that can address various disease states. By modifying disease-causing pathways, Halda Therapeutics seeks to enable healthcare providers to offer tailored therapies to patients, enhancing the effectiveness of treatment based on individual patient needs.

Autobahn Therapeutics

Series C in 2024
Autobahn Therapeutics, Inc. is a biotechnology company based in San Diego, California, focused on developing small molecule therapies for central nervous system (CNS) disorders. Since its incorporation in 2017, Autobahn has aimed to address significant unmet needs in neuropsychiatry and neuroimmunology through its innovative brain-targeting chemistry platform. The company's leading candidate, ABX-002, is a thyroid hormone receptor beta agonist being investigated as a potential treatment for multiple sclerosis and adrenomyeloneuropathy, as well as an adjunctive therapy for major depressive disorder and bipolar disorder depression. Autobahn Therapeutics emphasizes precision tuning of CNS exposure, targeting validated clinical and biological markers to enhance therapeutic opportunities and patient outcomes.

Greywolf Therapeutics

Series B in 2024
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

Nivoda

Series B in 2024
Nivoda Limited is a business-to-business online marketplace based in London, with an additional office in Hong Kong, that specializes in the buying and selling of diamonds and jewelry. Founded in 2017, Nivoda simplifies the global jewelry trade by providing a platform that connects jewelry businesses with verified suppliers, allowing them to browse a wide selection of diamonds and gemstones. The marketplace enables users to purchase goods efficiently from anywhere in the world through a single checkout process, helping clients source diamonds at competitive prices while minimizing logistical hurdles and additional costs associated with international purchases. Nivoda's aim is to enhance profits and accelerate growth for jewelry businesses by streamlining the sourcing process.

Quantum Circuits

Venture Round in 2024
Quantum Circuits, Inc. specializes in the development and manufacture of quantum computers utilizing superconducting devices. Founded in 2015 and located in New Haven, Connecticut, the company aims to innovate in the field of quantum computing by delivering full-stack systems that efficiently scale. Led by Dr. Robert Schoelkopf, a prominent figure in quantum science, Quantum Circuits employs a unique dual-rail quantum qubit design that incorporates built-in hardware error detection and conversion. This approach allows for a highly scalable error-corrected system, requiring significantly fewer physical qubits per logical qubit and providing a more efficient pathway to fault-tolerant quantum computing. By focusing on solid-state quantum bits, the company enables clients to perform error-free computations, thereby accelerating research and advancing the practical applications of quantum technology.

Qlaris Bio

Series B in 2024
Qlaris Bio, Inc. is a clinical-stage biotechnology company based in Wellesley, Massachusetts, focused on developing innovative therapies for serious ophthalmic diseases. Founded in 2017, the company is working on QLS-101, a therapy aimed at reducing intraocular pressure, a critical factor in conditions such as glaucoma. Qlaris Bio explores novel mechanisms to address episcleral venous pressure, which significantly contributes to intraocular pressure, thereby aiming to mitigate the risk of blindness associated with both Primary Open Angle Glaucoma and Normal Tension Glaucoma. The company also targets high unmet medical needs in pediatric rare diseases related to intraocular pressure disturbances, where effective treatment options are currently limited.

Pathios Therapeutics

Series B in 2024
Pathios Therapeutics Limited is an early-stage drug discovery company based in Oxford, United Kingdom, founded in 2017. The company is dedicated to developing therapies for autoimmune diseases and cancer, focusing on small molecule inhibitors that target the pH-sensing G protein-coupled receptor GPR65. These inhibitors are designed to mitigate the immunosuppressive polarization of immune cells, such as tumor-associated macrophages, which is often stimulated by the acidic microenvironment present in tumors. By employing a rigorous scientific approach that includes insights from human genetics and advanced cellular immunology, Pathios aims to generate novel therapeutics that can address advanced solid tumors and other significant medical needs in immuno-oncology.

Alterome Therapeutics

Series B in 2024
Alterome Therapeutics is a biotechnology company focused on precision oncology, dedicated to developing targeted therapeutics that specifically address validated oncogenic drivers in cancer. The firm aims to discover and create alteration-specific therapies that provide hope and improved treatment options for individuals affected by cancer. By concentrating on high-value oncogenic alterations, Alterome Therapeutics seeks to enhance the effectiveness of cancer treatments and support healthcare providers in their efforts to combat the disease.

Lily AI

Series B in 2024
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.

Nocion Therapeutics

Series B in 2024
Nocion Therapeutics, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, established in 2017. The company focuses on developing novel therapeutics called "nocions," which are designed to treat conditions associated with neurogenic inflammation. These nocions specifically target activated sensory neurons, entering nociceptors through large-pore channels that open in response to stimulation. This mechanism allows for the selective blocking of sodium channels, providing targeted and sustained relief for serious conditions such as cough, itch, pain, and inflammation. By offering an alternative to traditional small molecule anesthetics, Nocion Therapeutics aims to deliver more effective treatment options for patients suffering from these debilitating symptoms.

AgomAb Therapeutics

Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.

Acesion Pharma

Series B in 2023
Acesion Pharma ApS is a biotech company based in Copenhagen, Denmark, founded in 2011. The company specializes in the development of medical drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. Acesion Pharma focuses on creating SK channel inhibitors, which target specific ion channels in heart cells that are essential for generating the electrical signals that regulate heart rhythm. By inhibiting these channels, the company aims to provide safe and tolerable chronic treatments that prevent the recurrence of AF and support the maintenance of a normal heart rhythm.

Kepler

Series C in 2023
Kepler Communications Inc. specializes in satellite communications by designing, developing, and operating satellite infrastructure for space-based connectivity. The company focuses on creating a network of Low-Earth Orbit satellites that facilitate communication for various applications, including connecting space stations and devices. Its offerings include PolarConnect, which allows organizations in extreme environments to maintain global connectivity, and the Global Data Service, a high-bandwidth solution for transferring large data files from remote locations to the internet. Kepler is also developing everywhereIOT, a solution aimed at providing reliable, low-power connectivity for Internet of Things devices worldwide. Established in 2015 and headquartered in Toronto, Canada, Kepler serves diverse industries such as maritime, natural resources, research, defense, and logistics, positioning itself as a leader in addressing connectivity challenges in both terrestrial and space environments.

Greywolf Therapeutics

Series B in 2023
Grey Wolf Therapeutics is a biotechnology company based in Oxford, United Kingdom, focused on developing innovative immunotherapies for oncology. Founded in 2017, the company aims to enhance the visibility of non-responsive tumors to the immune system by directly modifying tumor cells. Its approach involves targeting endoplasmic reticulum aminopeptidases (ERAP) 1 and 2 within the antigen presentation pathway, which increases the neoantigen repertoire on tumor cells. This strategy is designed to improve the effectiveness of immunotherapy in treating cancer. Grey Wolf collaborates with leading academic and commercial partners to advance its drug discovery initiatives and deliver clinical candidates against well-validated targets in the field of immuno-oncology.

WorkMotion

Series B in 2022
WorkMotion is a global HR platform headquartered in Berlin, Germany, that facilitates the hiring and onboarding of international employees. Founded in 2020, the company offers a cloud-based workforce management platform that allows employers to recruit and manage employees worldwide without the need to establish legal entities in foreign countries. WorkMotion streamlines the hiring processes, consolidates global payroll accounting, and supports the management of freelancers, enabling organizations to efficiently hire and pay remote employees from around the globe.

Appsmith

Series B in 2022
Appsmith is a developer of an open-source low-code application platform established in mid-2019. The platform enables developers to efficiently build, deploy, and manage custom internal applications, particularly focusing on CRUD functionalities. With over 5 million downloads and usage among more than 1,000 enterprises across over 100 countries, Appsmith aims to simplify the development of internal tools by streamlining operations, automating processes, and facilitating the integration of various applications and data. Additionally, the platform enhances legacy applications by allowing developers to incorporate new features, all while maintaining enterprise-grade security and governance.

Lily AI

Venture Round in 2022
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.

Dusty Robotics

Series B in 2022
Dusty Robotics, Inc. specializes in providing automated layout services for the construction industry through its innovative robot-powered tools. Founded in 2018 and based in Mountain View, California, the company offers the FieldPrinter, which translates digital building information modeling (BIM) designs into accurate, constructible layouts directly on construction-site floors. By synchronizing BIM information with on-site requirements, Dusty Robotics eliminates manual steps in the workflow, enhancing efficiency and reducing waste in labor and materials. The company serves a diverse range of clients, including owners, general contractors, subcontractors, and builders, aiming to streamline the design-build-operate lifecycle in construction projects.

Lev

Series B in 2022
Lev Inc is a New York-based company founded in 2019 that specializes in financial services, particularly in lending and capital management solutions for commercial real estate transactions. The company has developed a technology platform designed to digitize these transactions, utilizing machine learning and artificial intelligence to analyze historical data and lender activity. This innovative approach allows Lev to identify optimal financing scenarios and connect clients with appropriate lenders. Additionally, the platform facilitates communication and negotiation on behalf of clients, streamlining the process of securing financing for property transactions.

BoostUp.ai

Series B in 2022
BoostUp.ai, Inc. operates a sales intelligence platform based in Santa Clara, California, designed to enhance sales operations by improving forecasting accuracy and efficiency. The platform analyzes both macro and micro-level risks, including sales forecasts, pipeline dynamics, and seller behavior, transforming unstructured data into actionable insights. By creating a connected experience across revenue operations, BoostUp.ai automates processes, enhances transparency, and identifies risks and opportunities within the sales pipeline. This not only drives team efficiency but also fosters high-performing sales teams, ultimately boosting sales execution and revenue growth. Numerous prominent companies utilize BoostUp.ai to achieve predictable revenue and enhance their sales processes.

Hermeus

Series B in 2022
Hermeus Corporation, founded in 2018 and headquartered in Atlanta, Georgia, specializes in the development of hypersonic aircraft designed to enhance global transportation. The company's Mach 5 jets are capable of flying at speeds exceeding five times the speed of sound, significantly reducing travel times for long-haul flights. For instance, a journey from New York to London can be completed in just 90 minutes, compared to the typical seven-hour duration. Hermeus aims to improve safety and efficiency in business class air travel while allowing for seamless integration with existing aviation infrastructure. This innovative approach not only accelerates travel but also fosters enhanced connectivity among global cities.

Instrumental

Series C in 2022
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to autonomously operate, learn, and adapt. This innovative approach significantly reduces scrap and rework costs for manufacturers, allowing them to address issues promptly and maintain higher production yields. The company's solutions are implemented in various global assembly lines, particularly among leading manufacturers. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, Instrumental aims to revolutionize the manufacturing industry by transforming inefficiencies into opportunities. In addition to its software offerings, Instrumental provides a range of services including performance analysis, architecture and design, and management consulting, catering to both commercial clients and government agencies. Based in Saint Paul, Minnesota, Instrumental has been active since 1991, focusing on creating impactful technological advancements in data-intensive environments.

Taptap Send

Series B in 2021
Taptap Send is a mobile application that facilitates instant money transfers for immigrants sending funds back to Africa at low costs. Launched in the summer of 2018, the platform has successfully processed hundreds of millions of dollars and serves hundreds of thousands of customers. It operates in seven European countries and enables payments to various countries, including Ivory Coast, Senegal, Mali, Ghana, Guinea, Cameroon, Bangladesh, Kenya, Madagascar, Zambia, Vietnam, and the Democratic Republic of the Congo, with plans for further expansion. Taptap Send simplifies the remittance process by allowing users to transfer money directly to mobile money wallets using just a debit card, eliminating the need for physical deposits and saving time for its clients.

Apex.AI

Series B in 2021
Apex.AI, Inc. is a software company that focuses on developing solutions for autonomous mobility systems, particularly self-driving vehicles. Founded in 2017 and based in Palo Alto, California, the company offers Apex.OS, a software framework that simplifies the complexity of hardware and software integration through user-friendly APIs. Additionally, Apex.AI provides Apex.Autonomy, which is tailored for safety-critical applications, and MARV.Automotive, a versatile data management platform that facilitates data transfer between vehicles and the cloud. This platform allows for advanced analytics, data introspection, and team collaboration. Apex.AI's software products leverage open-source technologies, enabling developers to create secure and efficient applications for autonomous vehicles.

Edge Impulse

Series B in 2021
Edge Impulse is a software platform that facilitates the development of machine learning models optimized for edge devices, where data is collected either with or without connectivity. The platform streamlines the entire process of building, deploying, and scaling embedded machine learning applications, enabling developers to create intelligent devices. It supports the collection of real sensor data and incorporates live signal processing, allowing for the transformation of raw data into neural networks. Additionally, Edge Impulse offers capabilities for model testing and deployment to a variety of target devices, from microcontrollers to CPUs and GPUs, making it easier and faster for developers to manage machine learning applications for the edge.

Sounding Board

Series B in 2021
Sounding Board is a technology company that specializes in leadership development. It offers a platform that provides personalized coaching for leaders and managers, connecting them with qualified coaches via phone, video, and chat. The platform creates tailored development plans, automates administration tasks, and offers data visualization tools to track progress and measure impact. Sounding Board serves global enterprises across 11 countries, with a strong focus on user experience and high-quality coaching. It was founded in 2016 and is headquartered in Foster City, California.

Reibus

Series B in 2021
Reibus is an online marketplace designed for the buying and selling of metals, specifically targeting industrial markets. The company connects businesses with a network of metal suppliers, facilitating seamless transactions and logistics for metal transportation. Its platform includes features such as anonymous buying, real-time leads for sellers, and transparent shipping options. By providing a proprietary search tool and a streamlined materials listing process, Reibus aims to enhance price performance, minimize time to market, and expand market reach, ultimately reducing sales and marketing-related expenses for its users.

Clutch

Series B in 2021
Clutch is a technology company focused on transforming the car buying process by offering a fully online platform for purchasing high-quality certified vehicles. Customers can browse a diverse inventory of second-hand cars at competitive prices on Clutch's website, where they can complete their purchases without the need for showrooms or commissioned salespeople. The platform simplifies the car buying experience by providing easier financing options and delivering vehicles directly to customers' homes. Clutch aims to enhance customer satisfaction by delivering an enjoyable and convenient car buying experience while also making a positive impact in the communities it serves.

CompStak

Series C in 2021
CompStak, Inc. is a New York-based company that operates an online database focused on commercial lease comparables, providing comprehensive deal information such as tenant names, addresses, rent, square footage, and landlord concessions. Established in 2011, CompStak employs a crowd-sourced model to collect data from brokers, landlords, appraisers, and researchers, facilitating the exchange of lease comps. The platform is utilized by various stakeholders in the real estate sector, including private equity funds, banks, asset managers, real estate investment trusts, and hedge funds, to conduct asset valuations and analyses prior to significant investments. Additionally, institutional owners leverage CompStak's data to compare properties effectively. The company has formed a strategic partnership with Knowledge Cubed to enhance its data offerings.

TrueFort

Series B in 2021
TrueFort Inc. is a cybersecurity company based in Weehawken, New Jersey, founded in 2015. It specializes in real-time application and cloud workload protection solutions, focusing on securing critical applications and infrastructure. The company's flagship platform, Fortress, offers a unique approach to security by leveraging advanced behavioral analysis, machine intelligence, and automation. This platform supports zero trust application environments and addresses various security challenges through a unified solution that enhances visibility and protection against cyber threats. TrueFort's technology enables clients to utilize agents already deployed in their systems, facilitating seamless integration while significantly reducing risks associated with excessive trust.

Embroker

Series C in 2021
Embroker, Inc. is a digital insurance brokerage that specializes in providing insurance services to small and mid-sized businesses. Founded in 2015 and headquartered in San Francisco, with additional offices in Chicago, Boston, Denver, and New York, Embroker utilizes an online platform to streamline the process of purchasing, managing, and analyzing commercial insurance policies. The platform allows clients to automate the sharing, requesting, and tracking of proof of coverage, as well as monitor claims in real-time. Embroker offers a wide range of insurance products, including Commercial General Liability, property insurance, professional liability, and employee benefits, among others. The company also provides tools for peer comparison, enabling clients to benchmark their policies against industry standards. By combining technology with broker expertise, Embroker aims to enhance the efficiency and effectiveness of the $800 billion property and casualty insurance market, helping businesses save time and secure optimal coverage.

Kepler

Series B in 2021
Kepler Communications Inc. specializes in satellite communications by designing, developing, and operating satellite infrastructure for space-based connectivity. The company focuses on creating a network of Low-Earth Orbit satellites that facilitate communication for various applications, including connecting space stations and devices. Its offerings include PolarConnect, which allows organizations in extreme environments to maintain global connectivity, and the Global Data Service, a high-bandwidth solution for transferring large data files from remote locations to the internet. Kepler is also developing everywhereIOT, a solution aimed at providing reliable, low-power connectivity for Internet of Things devices worldwide. Established in 2015 and headquartered in Toronto, Canada, Kepler serves diverse industries such as maritime, natural resources, research, defense, and logistics, positioning itself as a leader in addressing connectivity challenges in both terrestrial and space environments.

Archipelago

Series B in 2021
Archipelago Analytics, Inc., based in San Francisco, California, was incorporated in 2018 and specializes in utilizing artificial intelligence to enhance risk management for large commercial property owners. The company's platform digitizes risk data, facilitating improved insurance outcomes and overall resilience. By enabling the efficient movement of critical information through the insurance value chain—from clients to brokers and capacity providers—Archipelago aims to lower the total cost of risk for its users, ensuring they receive timely and relevant data to make informed decisions.

OncoResponse

Series C in 2021
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.

Tyra Biosciences

Series B in 2021
Tyra Biosciences is a clinical-stage biotechnology company based in Carlsbad, California, that specializes in developing small molecule therapies for cancer treatment. Founded in 2018, the company aims to address drug resistance in cancer therapies through its proprietary SNÅP platform, which facilitates rapid and precise drug design by generating iterative molecular snapshots. Tyra is particularly focused on creating selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family, which are implicated in approximately 7% of all cancers. The company's lead product candidate, TYRA-300, specifically targets FGFR3 and is initially aimed at patients with metastatic urothelial carcinoma of the bladder and urinary tract. Through its innovative approach, Tyra Biosciences seeks to improve treatment outcomes for cancer patients by providing alternatives to existing therapies.

Axis Security

Series C in 2021
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in providing Zero Trust Network Access solutions, focusing on secure remote access to applications. The company's platform employs application isolation technology and a context-aware security approach, evaluating various factors to ensure that only authorized users can access specific resources within a network. This allows organizations to maintain control over sensitive information while enabling access for employees, partners, and other stakeholders. Through its cloud security and analytics solutions, Axis Security aims to enhance data protection and streamline secure access to business applications.

Day One Biopharmaceuticals

Series B in 2021
Day One Biopharmaceuticals is a clinical-stage biotechnology company that specializes in developing targeted cancer therapies for patients of all ages, with a particular focus on pediatric patients. Recognizing the advancements in cancer research, the company aims to create treatments that can benefit both children and adults diagnosed with genetically defined cancers. Day One Biopharmaceuticals prioritizes the rapid development of therapies to meet the urgent needs of families facing cancer diagnoses. Their lead product candidate, DAY101, is an oral, highly-selective pan-RAF kinase inhibitor designed to penetrate the brain, addressing a significant treatment gap in pediatric oncology. By licensing and acquiring promising products from research institutions and other companies, Day One Biopharmaceuticals strives to bring effective medicines to market for those impacted by cancer.

Vivace Therapeutics

Series C in 2020
Vivace Therapeutics, Inc. is a drug discovery and development company focused on creating cancer therapies that target the Hippo pathway, which plays a crucial role in tissue regeneration and organ development. Established in 2014 and located in the San Francisco Bay Area, Vivace Therapeutics employs an innovative approach to develop small molecule treatments aimed at improving patient outcomes in oncology. The company collaborates with leading academic institutions to advance research and develop therapies that can be used alone or in combination with existing treatments. With a commitment to enhancing cancer care, Vivace Therapeutics is dedicated to delivering novel solutions that can help patients combat cancer more effectively.

Dragos

Series C in 2020
Dragos is an industrial cybersecurity company specializing in protecting critical infrastructure worldwide. It develops software that provides real-time visibility into Industrial Control Systems (ICS) and Operational Technology (OT) networks, enabling early detection of threats and proactive mitigation strategies. The company's solutions are optimized for emerging technologies like the Industrial Internet of Things (IIoT), serving clients across power and water utilities, energy, and manufacturing sectors to enhance their overall security posture.

Vineti

Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Axis Security

Series B in 2020
Axis Security Inc. is a cybersecurity company founded in 2018 and based in Palo Alto, California. It specializes in providing Zero Trust Network Access solutions, focusing on secure remote access to applications. The company's platform employs application isolation technology and a context-aware security approach, evaluating various factors to ensure that only authorized users can access specific resources within a network. This allows organizations to maintain control over sensitive information while enabling access for employees, partners, and other stakeholders. Through its cloud security and analytics solutions, Axis Security aims to enhance data protection and streamline secure access to business applications.

Papa

Series B in 2020
Papa, Inc. operates an online platform designed to connect college and nursing students with senior citizens in need of assistance and companionship. Founded in 2016 and headquartered in Miami, Florida, the platform facilitates a range of services including transportation for medical appointments, grocery shopping, house chores, technology assistance, and caregiving. By enabling older adults to access support from vetted companions, Papa helps them maintain their independence and enhances their quality of life while living at home. The platform not only addresses the practical needs of seniors but also fosters social connections, ensuring they receive both functional assistance and companionship.

nTopology

Series C in 2020
nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to autonomously operate, learn, and adapt. This innovative approach significantly reduces scrap and rework costs for manufacturers, allowing them to address issues promptly and maintain higher production yields. The company's solutions are implemented in various global assembly lines, particularly among leading manufacturers. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, Instrumental aims to revolutionize the manufacturing industry by transforming inefficiencies into opportunities. In addition to its software offerings, Instrumental provides a range of services including performance analysis, architecture and design, and management consulting, catering to both commercial clients and government agencies. Based in Saint Paul, Minnesota, Instrumental has been active since 1991, focusing on creating impactful technological advancements in data-intensive environments.

Mynd

Series C in 2020
Mynd is a technology-driven property management company specializing in single-family rental properties. It offers a suite of services, including property marketing, tenant screening, rent collection, maintenance, and accounting, to help investment property owners efficiently manage their assets and maximize returns. The company leverages technology and data analytics to enhance property performance, ensure timely communication, and provide property owners with real-time information and financial reports via its digital platforms.

READY Robotics

Series B in 2020
READY Robotics Corp., founded in 2016 and headquartered in Baltimore, Maryland, specializes in developing ForgeOS, an innovative industrial operating system designed for robotics and automation. This platform utilizes patented technology to enable manufacturers to deploy and manage robots and automation systems through a standardized suite of low-code applications. ForgeOS is particularly suited for high-mix, low-volume manufacturing environments, which have traditionally posed challenges for automation. The system allows operators to control and program a wide range of robotic devices and industrial automation equipment from major brands through a single interface, minimizing the need for extensive training. By connecting to hundreds of robot models and thousands of industrial devices, READY Robotics enhances productivity and streamlines operations in complex manufacturing settings.

Ladder

Series C in 2020
Ladder is a digital life insurance company founded in 2015 and headquartered in Palo Alto, California. It provides flexible term life insurance coverage that can be obtained quickly and efficiently, allowing policyholders to save up to 40%. The company employs an all-digital architecture and real-time underwriting, which simplifies the life insurance application process by eliminating the need for commissioned sales agents. This approach enables financially savvy consumers to apply for insurance online without the need for in-person meetings. Ladder offers coverage options up to $8 million and operates across all 50 states, making life insurance more accessible and affordable for a wide range of individuals.

Vineti

Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Berkshire Grey

Series B in 2020
Berkshire Grey, Inc. specializes in developing artificial intelligence-driven robotic and automated material handling systems aimed at enhancing omnichannel fulfillment. Founded in 2013 and based in Lexington, Massachusetts, the company offers a range of solutions, including AI software, robotic arms, mobile robotic systems, and advanced sorting technologies. Its systems leverage artificial intelligence, computer vision, and machine learning to automate tasks traditionally performed by humans, thereby increasing accuracy and throughput in logistics and supply chain operations. Berkshire Grey's technology is designed to handle diverse products and packaging types, providing a significant competitive advantage to its customers. The company primarily generates its revenue from North America and operates as a subsidiary of SoftBank Group Corp.

Capella Space

Series B in 2019
Capella Space is a commercial satellite imaging company based in San Francisco, California, founded in 2016. It operates a constellation of small satellites equipped with synthetic aperture radar (SAR) technology, capable of providing high-resolution Earth observation imagery at 50 centimeters. This technology allows for continuous monitoring of the Earth's surface, regardless of weather conditions, including clouds, smoke, and darkness. Capella Space's services support various industries, including maritime domain awareness, agriculture, infrastructure monitoring, and disaster response. The company aims to enhance decision-making related to commerce, conservation, and security by delivering timely and flexible geospatial data. Its capabilities are particularly valuable for applications involving economic activity estimation, urban planning, and search and rescue operations.

Astra

Series C in 2019
Astra is a rocket launch startup that provides satellite delivery and launch services. It offers online reservations for payload deliveries to both sun-synchronous and low-inclination orbits. Astra also offers dedicated launch services of 50kg-150kg payloads to 500km SSO reference orbit in 2020 and 2021. The company focuses on providing cost-effective and frequent access to space for small satellite payloads. Astra aims to simplify the process of launching payloads into space by developing lightweight and agile rockets that can be found from various locations. Astra has been actively conducting launch campaigns to demonstrate its capabilities and improve its technology. As with any ambitious space venture, Astra has faced its fair share of challenges and setbacks in developing and launching rockets.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

ScaleFactor

Series C in 2019
ScaleFactor, Inc. is a provider of accounting and finance software that aims to streamline business accounting and financial operations. Founded in 2014 and headquartered in Austin, Texas, ScaleFactor offers automated bookkeeping, proactive alerts, and a suite of financial analysis tools. The software utilizes machine learning to process and categorize financial transactions in real-time, enabling business owners and managers to gain actionable insights from their financial data. In addition to its software solutions, ScaleFactor provides a range of services including IT and accounting integration, HR and payroll support, CFO advisory, benefits administration, and compliance. The company serves various industries, including professional services, restaurants, retail, technology, and wellness, and maintains strategic partnerships to enhance its offerings. ScaleFactor operates additional offices in Denver, New York, Santa Monica, and Coquitlam, Canada.

MindTickle

Series C in 2019
MindTickle is a global, privately-held company that specializes in providing a data-driven sales readiness platform aimed at enhancing the effectiveness of customer-facing teams. Headquartered in San Francisco, California, and Pune, India, MindTickle's platform is utilized by sales teams across various industries to bridge knowledge and skill gaps through automated training paths, adaptive learning, and virtual coaching tools. The company's solution incorporates on-demand online training, bite-sized mobile updates, gamification, and role-play, enabling enterprises to track onboarding progress and certify readiness. By leveraging MindTickle, organizations can improve sales performance, achieve larger deal sizes, increase win rates, and shorten sales cycles, ultimately driving growth and maximizing business impact.

nTopology

Series B in 2019
nTopology, Inc. is an engineering software company that develops tools for manufacturing, focusing on design, simulation, and advanced manufacturing processes. Its flagship product, nTopology, allows engineers to create lightweight and optimized parts tailored to their functional requirements. The platform includes features such as Lightweighting, Architected Materials, Topology Optimization, Additive Manufacturing, and Design Analysis, which help eliminate geometry bottlenecks and enhance collaboration among teams. nTopology serves various industries, including aerospace and defense, medical, automotive, consumer products, and education. Founded in 2013 and headquartered in New York, the company aims to streamline workflows and integrate synthesized geometry with simulation data to produce manufacturing-ready models.

CompStak

Series B in 2019
CompStak, Inc. is a New York-based company that operates an online database focused on commercial lease comparables, providing comprehensive deal information such as tenant names, addresses, rent, square footage, and landlord concessions. Established in 2011, CompStak employs a crowd-sourced model to collect data from brokers, landlords, appraisers, and researchers, facilitating the exchange of lease comps. The platform is utilized by various stakeholders in the real estate sector, including private equity funds, banks, asset managers, real estate investment trusts, and hedge funds, to conduct asset valuations and analyses prior to significant investments. Additionally, institutional owners leverage CompStak's data to compare properties effectively. The company has formed a strategic partnership with Knowledge Cubed to enhance its data offerings.

Gen.G esports

Series B in 2019
Gen.G esports is a prominent professional esports organization founded in 2017, with its headquarters in Seoul, South Korea, and additional offices in Los Angeles and Shanghai. The organization is known for bridging the esports markets in the United States and Asia, operating top teams in renowned games like Overwatch and League of Legends, and featuring a celebrated all-female Fortnite team. Gen.G has achieved significant recognition, including being ranked among the world's most valuable esports companies. Its teams have won seven global championships, reflecting their competitive prowess. Beyond team management, Gen.G offers a range of services such as coaching, training, and business development, while also creating platforms for global brands to engage with gaming fans. The company is committed to fostering inclusivity in esports through initiatives like #TeamBumble and the Gen.G Elite Esports Academy, which integrates academic programs with esports training. Gen.G's mission emphasizes leveraging the power of gaming to empower both fans and athletes in their pursuits, establishing it as a leader in the evolving landscape of sports entertainment.

Roman

Series B in 2019
Roman is a men's health company that offers online diagnosis and discreet shipping of safe erectile dysfunctional medication. The company was launched in 2017 as a vertical of Ro, a healthcare technology company.

JOOR

Series C in 2019
JOOR, Inc. is an online global fashion marketplace that facilitates wholesale buying by connecting brands and retailers through a digital platform. Founded in 2010 and headquartered in New York, with additional offices in cities such as Los Angeles, London, Milan, Paris, Sydney, and Melbourne, JOOR aims to enhance the wholesale purchasing process. The platform streamlines operations by eliminating manual, error-prone tasks, thereby allowing brands and retailers to focus on increasing revenue, reducing costs, and enhancing customer experiences. Additionally, JOOR leverages data analytics to enable users to monitor performance effectively. Through its innovative approach, JOOR serves as a vital resource in the retail industry, supporting businesses in navigating their wholesale transactions more efficiently.

PerimeterX

Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Komprise

Series C in 2019
Komprise, Inc. is a data management company that specializes in intelligent software designed to store, organize, and analyze both on-premise and cloud-based data. Founded in 2014 and headquartered in Campbell, California, Komprise offers a multi-cloud data management-as-a-service platform that enables users to analyze and mobilize file and object data across various cloud environments. The company’s solution focuses on optimizing data storage by moving unstructured data to secondary storage based on factors such as age, usage, and security criteria. This approach allows organizations to effectively manage their data lifecycle through analytics, replication, archiving, and migration, ensuring that data remains accessible and appropriately situated. Komprise has established a strategic partnership with Ochser Consulting Group to enhance its service offerings.

Contentsquare

Series C in 2019
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.

Kustomer

Series C in 2019
Kustomer, Inc. is a customer service software company that specializes in developing a customer relationship management (CRM) platform designed to enhance enterprise customer service experiences. Founded in 2015 and headquartered in New York, with an additional office in Durham, North Carolina, Kustomer's platform consolidates data from various sources, allowing businesses to manage inquiries and customer relationships effectively. It provides a comprehensive view of customer interactions, including buying history and previous help desk conversations, enabling agents to address customer queries and issues efficiently. Kustomer serves a range of notable brands, helping them deliver exceptional service and support through a unified timeline view, thereby streamlining communication and improving customer satisfaction.

ScaleFactor

Series B in 2019
ScaleFactor, Inc. is a provider of accounting and finance software that aims to streamline business accounting and financial operations. Founded in 2014 and headquartered in Austin, Texas, ScaleFactor offers automated bookkeeping, proactive alerts, and a suite of financial analysis tools. The software utilizes machine learning to process and categorize financial transactions in real-time, enabling business owners and managers to gain actionable insights from their financial data. In addition to its software solutions, ScaleFactor provides a range of services including IT and accounting integration, HR and payroll support, CFO advisory, benefits administration, and compliance. The company serves various industries, including professional services, restaurants, retail, technology, and wellness, and maintains strategic partnerships to enhance its offerings. ScaleFactor operates additional offices in Denver, New York, Santa Monica, and Coquitlam, Canada.

Bellhop

Series C in 2018
Bellhops, Inc. is a moving services company based in Chattanooga, Tennessee, founded in 2013. It specializes in providing truck, trailer, storage unit, and mobile storage container loading and unloading services, along with heavy lifting assistance. The company employs a technology-driven model that connects athletic students with individuals and businesses requiring moving help, facilitating both local and long-distance moves in 55 cities across the United States. By offering an online platform for booking services, Bellhop aims to enhance the customer experience, providing a transparent review system and a personal dashboard for users to manage their moving process. The company focuses on delivering cost-effective solutions while addressing the needs of small and medium-scale moves.

Embroker

Series B in 2018
Embroker, Inc. is a digital insurance brokerage that specializes in providing insurance services to small and mid-sized businesses. Founded in 2015 and headquartered in San Francisco, with additional offices in Chicago, Boston, Denver, and New York, Embroker utilizes an online platform to streamline the process of purchasing, managing, and analyzing commercial insurance policies. The platform allows clients to automate the sharing, requesting, and tracking of proof of coverage, as well as monitor claims in real-time. Embroker offers a wide range of insurance products, including Commercial General Liability, property insurance, professional liability, and employee benefits, among others. The company also provides tools for peer comparison, enabling clients to benchmark their policies against industry standards. By combining technology with broker expertise, Embroker aims to enhance the efficiency and effectiveness of the $800 billion property and casualty insurance market, helping businesses save time and secure optimal coverage.

Dragos

Series B in 2018
Dragos is an industrial cybersecurity company specializing in protecting critical infrastructure worldwide. It develops software that provides real-time visibility into Industrial Control Systems (ICS) and Operational Technology (OT) networks, enabling early detection of threats and proactive mitigation strategies. The company's solutions are optimized for emerging technologies like the Industrial Internet of Things (IIoT), serving clients across power and water utilities, energy, and manufacturing sectors to enhance their overall security posture.

OncoResponse

Series B in 2018
OncoResponse Inc. is an immuno-oncology biotechnology company based in Houston, Texas, focused on developing innovative cancer therapies. The company utilizes a proprietary human antibody platform to identify fully human monoclonal antibodies targeting immuno-oncology pathways. By probing the adaptive immune systems of cancer patients who have shown exceptional responses to checkpoint inhibitors, OncoResponse aims to discover novel therapeutic antibodies. Its research emphasizes addressing immunosuppressive myeloid biology and enhancing immune activation, with the goal of transforming cold tumors into hot tumors that are more responsive to treatment. Through its advanced antibody pipeline, OncoResponse is dedicated to providing effective solutions for cancer treatment.

Cargomatic

Series B in 2018
Cargomatic, Inc. operates an online platform that connects shippers with pre-screened and qualified carriers in real-time, primarily serving the Southern California region. Established in 2013 and based in Venice, California, Cargomatic has developed a technology-driven network for local truck availability. Shippers can submit loads and quickly find nearby trucks to meet their logistics needs. Since its launch in early 2014, the platform has facilitated tens of thousands of deliveries across California, Chicago, and metropolitan New York. By streamlining the booking process and providing real-time tracking capabilities, Cargomatic enhances service levels, improves pick-up and delivery rates, and allows customers to manage outsourced vendors efficiently. The company operates as a subsidiary of Genesee & Wyoming Inc.

Antiva Biosciences

Series C in 2018
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.

Kustomer

Series B in 2018
Kustomer, Inc. is a customer service software company that specializes in developing a customer relationship management (CRM) platform designed to enhance enterprise customer service experiences. Founded in 2015 and headquartered in New York, with an additional office in Durham, North Carolina, Kustomer's platform consolidates data from various sources, allowing businesses to manage inquiries and customer relationships effectively. It provides a comprehensive view of customer interactions, including buying history and previous help desk conversations, enabling agents to address customer queries and issues efficiently. Kustomer serves a range of notable brands, helping them deliver exceptional service and support through a unified timeline view, thereby streamlining communication and improving customer satisfaction.

PACT Pharma

Series B in 2018
PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment, specifically through neoantigen-specific adoptive T-cell therapies aimed at solid tumors. The company utilizes bioinformatics to analyze the DNA and RNA of patients' tumors and normal tissues, identifying candidate neoantigen peptides that can stimulate targeted antitumor T-cell responses. By recognizing unique neo-epitopes associated with individual cancers, PACT Pharma enables the engineering of autologous T cells designed to specifically target and eliminate tumor cells expressing these neoantigens. Founded in 2016 and based in South San Francisco, California, PACT Pharma is dedicated to advancing innovative treatment options for patients with cancer.

Mynd

Series B in 2018
Mynd is a technology-driven property management company specializing in single-family rental properties. It offers a suite of services, including property marketing, tenant screening, rent collection, maintenance, and accounting, to help investment property owners efficiently manage their assets and maximize returns. The company leverages technology and data analytics to enhance property performance, ensure timely communication, and provide property owners with real-time information and financial reports via its digital platforms.

Rocketrip

Series C in 2018
Rocketrip, Inc. is a travel management platform that incentivizes employees to make cost-effective travel decisions for business purposes. Founded in 2013 and based in New York, the platform provides real-time insights into travel expenses, helping employees understand reasonable spending limits. By establishing a custom-calibrated Price to Beat, Rocketrip motivates employees to select lower-cost options for flights, car rentals, and hotel accommodations, thereby enabling them to earn rewards for saving the company money. The platform integrates seamlessly with existing online booking processes, ensuring minimal disruption. Rocketrip is utilized by notable enterprises such as iHeartMedia, Feld Entertainment, and Twitter, and operates as a subsidiary of Mondee Holdings Inc.

Vineti

Series B in 2018
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Arvinas

Series C in 2018
Arvinas, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, that specializes in the discovery, development, and commercialization of innovative therapies aimed at degrading disease-causing proteins. The company's lead product candidates include ARV-110, a proteolysis targeting chimera (PROTAC) currently in phase I clinical trials for metastatic castration-resistant prostate cancer, and ARV-471, which targets the estrogen receptor for patients with metastatic ER-positive/HER2-negative breast cancer. In addition to these, Arvinas is developing various other PROTACs aimed at degrading clinically relevant androgen receptor mutations and treatments for neurodegenerative diseases, including tauopathies. The company has established collaborations with prominent pharmaceutical firms such as Pfizer Inc., Genentech, and Bayer AG, enhancing its research capabilities and reach within the biopharmaceutical landscape. Founded in 2015, Arvinas aims to improve patient outcomes by eliminating harmful proteins from the body through its proprietary technology.

IDEAYA Biosciences

Series B in 2018
IDEAYA Biosciences is an oncology-focused biotechnology company based in South San Francisco, California, dedicated to the discovery and development of targeted therapeutics for genetically defined patient populations. The company specializes in precision medicine using molecular diagnostics and synthetic lethality approaches to address cancer treatment. Its lead product candidate, IDE196, is a protein kinase C inhibitor currently undergoing Phase 1/2 clinical trials for cancers associated with GNAQ or GNA11 gene mutations. IDEAYA's preclinical pipeline includes programs targeting various mechanisms related to DNA damage and repair, such as MAT2A for tumors with MTAP deletions, Pol-theta for homologous recombination deficiency, and PARG for BRCA2 mutation context. The company collaborates with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase, while also engaging in partnerships for clinical trials with Pfizer and GlaxoSmithKline. Founded in 2015, IDEAYA aims to advance innovative therapies for enhancing immunotherapy responses and improving patient outcomes in oncology.

Imanis Data

Series B in 2018
Imanis Data, based in San Jose, California, specializes in subscription-based data availability management solutions designed for large-scale enterprises. The company's flagship product, FastFind, is a metadata catalog that enhances Big Data applications, facilitating management across various platforms such as Cassandra and Hive through an intuitive graphical interface. This solution allows users to implement role-based access control, enable self-service access, and monitor analytics related to data consumption and system health. Additionally, Imanis Data offers a backup and recovery platform that proactively detects ransomware attacks and identifies potential data loss. Formerly known as Talena, Imanis Data was incorporated in 2012 and operates as a subsidiary of Cohesity. The company is focused on leveraging advanced technologies to provide robust and scalable data management solutions, ensuring data resiliency for petabyte-scale data sets, whether stored on-premises or in the cloud.

Contentsquare

Series B in 2018
Contentsquare is an AI-powered platform that provides rich and contextual insight through customer behaviors, feelings, and intent. The platform helps brands to transform their businesses digitally using digital experience analytics that allows them to take action through enterprise scale and build customer trust with security, privacy, and accessibility.

Apartment List

Series C in 2018
Apartment List, Inc., established in 2008 and headquartered in San Francisco, operates an online rental marketplace connecting renters and landlords across the United States. Its platform streamlines the housing search by offering personalized, curated listings based on users' preferences, ensuring a simple, enjoyable, and transparent process.

Ladder

Series B in 2018
Ladder is a digital life insurance company founded in 2015 and headquartered in Palo Alto, California. It provides flexible term life insurance coverage that can be obtained quickly and efficiently, allowing policyholders to save up to 40%. The company employs an all-digital architecture and real-time underwriting, which simplifies the life insurance application process by eliminating the need for commissioned sales agents. This approach enables financially savvy consumers to apply for insurance online without the need for in-person meetings. Ladder offers coverage options up to $8 million and operates across all 50 states, making life insurance more accessible and affordable for a wide range of individuals.

MindTickle

Series B in 2017
MindTickle is a global, privately-held company that specializes in providing a data-driven sales readiness platform aimed at enhancing the effectiveness of customer-facing teams. Headquartered in San Francisco, California, and Pune, India, MindTickle's platform is utilized by sales teams across various industries to bridge knowledge and skill gaps through automated training paths, adaptive learning, and virtual coaching tools. The company's solution incorporates on-demand online training, bite-sized mobile updates, gamification, and role-play, enabling enterprises to track onboarding progress and certify readiness. By leveraging MindTickle, organizations can improve sales performance, achieve larger deal sizes, increase win rates, and shorten sales cycles, ultimately driving growth and maximizing business impact.

UrbanSitter

Series C in 2017
UrbanSitter, Inc. is a childcare marketplace that connects parents with babysitters and nannies through shared connections. Founded in 2010 and based in San Francisco, the company operates in major cities including New York City, Chicago, Los Angeles, Seattle, Washington D.C., Boston, Denver, and San Diego. UrbanSitter offers an app and website that simplifies the process of finding, booking, and paying for trusted care across various needs, including child care, senior care, pet sitting, and household services. By leveraging a parent's personal network, UrbanSitter helps families find caregivers recommended by friends, co-workers, and local parents, ensuring a level of trust and reliability. The platform is particularly useful for last-minute childcare needs, boasting average response times of under three minutes. By addressing the challenges of securing reliable care, UrbanSitter provides families with essential support in their daily lives.

PerimeterX

Series B in 2017
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.

Unchained Labs

Series C in 2017
Unchained Labs is a life sciences tools company based in Pleasanton, California, specializing in solutions for biologics and gene therapy researchers. Established in 2014, it develops a range of products designed to enhance the efficiency and effectiveness of research in protein stability and formulation. Key offerings include the Optim platform, which allows researchers to measure multiple protein stability parameters simultaneously, and GRUNT, an automated system for biologic formulation preparation. In addition to these, the company provides various tools such as protein sizing systems, stability quantifiers, and automated buffer exchange systems. Unchained Labs serves biopharma and academic customers globally, distributing its products through partnerships in Europe, North and South America, Japan, and other Asian markets.

Vivace Therapeutics

Series B in 2017
Vivace Therapeutics, Inc. is a drug discovery and development company focused on creating cancer therapies that target the Hippo pathway, which plays a crucial role in tissue regeneration and organ development. Established in 2014 and located in the San Francisco Bay Area, Vivace Therapeutics employs an innovative approach to develop small molecule treatments aimed at improving patient outcomes in oncology. The company collaborates with leading academic institutions to advance research and develop therapies that can be used alone or in combination with existing treatments. With a commitment to enhancing cancer care, Vivace Therapeutics is dedicated to delivering novel solutions that can help patients combat cancer more effectively.

Glooko

Series C in 2017
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Iterum Therapeutics

Series B in 2017
Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing anti-infective therapies to address multi-drug resistant pathogens. Headquartered in Dublin, Ireland, the company is advancing its lead product, sulopenem, a novel penem compound available in both oral and intravenous formulations. Currently in Phase III clinical trials, sulopenem is being evaluated for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum aims to provide effective solutions to combat antibiotic resistance, particularly against a range of gram-negative, gram-positive, and anaerobic bacteria that are resistant to existing antibiotics. Founded in 2015, Iterum Therapeutics seeks to improve the lives of patients affected by serious and life-threatening infections globally.

Onkos Surgical

Series B in 2017
Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing advanced technologies and solutions for surgical oncologists. Founded in 2014, Onkos Surgical is dedicated to transforming the treatment of musculoskeletal cancers and complex orthopedic conditions. The company offers innovative products such as GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D printed limb salvage replacement. By leveraging cutting-edge techniques in virtual surgical planning, 3D modeling and printing, and personalized surgical planning, Onkos Surgical aims to enhance patient outcomes and improve the overall experience for both patients and healthcare professionals.

Antiva Biosciences

Series C in 2017
Antiva Biosciences is a biopharmaceutical company based in South San Francisco, California, focused on developing antiviral drugs to treat human papillomavirus (HPV) infections. Founded in 2012 and previously known as Hera Therapeutics, the company aims to prevent cancer by addressing precancerous lesions associated with HPV. Antiva's innovative approach involves localized therapeutics and small molecule antivirals designed to improve health outcomes for patients suffering from diseases linked to HPV and other viruses. The company's clinical programs target high-grade anal intraepithelial neoplasias and high-grade cervical intraepithelial neoplasias, utilizing a medicinal chemistry platform that emphasizes the development and commercialization of direct-acting antivirals.

UNIFi Software

Series B in 2017
Unifi Software, Inc. specializes in developing self-service data integration tools designed for both business users and IT professionals. Its primary products include the Unifi catalog, which leverages AI technology for data crawling and asset collection, facilitating the identification and processing of critical data assets while offering features such as user-friendly search, collaboration, and data governance. The company also offers the Unifi data platform, which aids business analysts in data acquisition, discovery, transformation, and management of unstructured data, while providing IT professionals with tools for user authorization and resource management. Available through the Microsoft Azure Marketplace, Unifi's solutions support various applications, including audience analytics and cloud migration. Founded in 2013 and based in San Mateo, California, Unifi Software operates as a subsidiary of Boomi, Inc.

Apartment List

Series B in 2016
Apartment List, Inc., established in 2008 and headquartered in San Francisco, operates an online rental marketplace connecting renters and landlords across the United States. Its platform streamlines the housing search by offering personalized, curated listings based on users' preferences, ensuring a simple, enjoyable, and transparent process.

Leanplum

Series C in 2016
Leanplum Inc. is a mobile marketing platform that specializes in enhancing engagement for brands through a unified, multichannel approach. Founded in 2012 and headquartered in San Francisco, with additional offices in New York, London, Bulgaria, and Amsterdam, Leanplum enables businesses to optimize their mobile applications and marketing efforts. The platform offers a range of services including messaging, automation, app editing, personalization, A/B testing, and analytics, allowing product teams to conduct real-time optimization tests and analyze results effectively. Renowned global brands such as Tinder, Grab, Tesco, and Zynga utilize Leanplum to orchestrate integrated campaigns that foster customer loyalty and drive growth. By transforming data into actionable insights, Leanplum helps companies understand user needs, delivering relevant experiences that enhance brand engagement and establish long-term customer relationships.

Glooko

Series C in 2016
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Chrono Therapeutics

Series B in 2016
Chrono Therapeutics Inc. is a pharmaceutical company based in Hayward, California, specializing in digital transdermal drug delivery systems. Founded in 2003, the company has developed SmartStop, a digital nicotine replacement therapy that incorporates a wearable device. This innovative solution allows for programmable delivery of nicotine, adjusting timing and dosage to effectively manage withdrawal symptoms and peak addiction triggers. By combining this transdermal therapy with real-time behavioral support, Chrono Therapeutics aims to enhance smoking cessation efforts and improve clinical outcomes for users. The leadership team brings extensive experience in product development, research and development, and a deep understanding of the smoking cessation market, positioning the company to play a significant role in addressing the smoking epidemic.

Sample6

Series C in 2016
Sample6 is a biotechnology company that specializes in the development of a synthetic-biology based diagnostic system for bacteria. Its innovative technology enables enrichment-free detection of harmful bacteria, identifying levels as low as 1 CFU/ml within just four hours. The proprietary Bioillumination Platform, created by a team of researchers including Professor Tim Lu from MIT, allows for the engineering of bioparticles that target specific unwanted bacteria, illuminating them for detection. This system is coupled with sensitive sensor technology that provides rapid on-site results without the need for a laboratory. Sample6 aims to enhance public health and safety by enabling quick and efficient detection of harmful bacteria across various industries, including food production, retail, and healthcare, addressing environments where humans and bacteria interact.

Rocketrip

Series B in 2016
Rocketrip, Inc. is a travel management platform that incentivizes employees to make cost-effective travel decisions for business purposes. Founded in 2013 and based in New York, the platform provides real-time insights into travel expenses, helping employees understand reasonable spending limits. By establishing a custom-calibrated Price to Beat, Rocketrip motivates employees to select lower-cost options for flights, car rentals, and hotel accommodations, thereby enabling them to earn rewards for saving the company money. The platform integrates seamlessly with existing online booking processes, ensuring minimal disruption. Rocketrip is utilized by notable enterprises such as iHeartMedia, Feld Entertainment, and Twitter, and operates as a subsidiary of Mondee Holdings Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.